P2RY12 and coronary artery disorder: In addition, several recent studies have suggested that P2Y12 inhibitors (clopidogrel or ticagrelor) as antiplatelet monotherapy have better efficacy than aspirin in patients with stable CAD or in patients after an ACS event [10,11,12,13,14,15,16,17,18].